-
Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Mar 10, 2025, 14:00 PM -
Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Software as a Medical Device: Current Regulations in North America and Europe
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Is there a GLP-1 Halo Effect? Potentially Better Overall Health Management Due to Starting GLP-1 for Weight Loss
Mar 10, 2025, 14:00 PM -
Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study
Mar 10, 2025, 14:00 PM -
A Comparative Assessment of LLM Agreement for Clinical Data Extraction Tasks
Mar 10, 2025, 14:00 PM -
The Cost of 340B to States
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Generalized Cost-Effectiveness Analysis with Dynamic Prevalence for Improving Health Equity Among Rare Diseases
Mar 10, 2025, 14:00 PM -
Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Mar 10, 2025, 14:00 PM -
Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
Mar 10, 2025, 14:00 PM -
Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women
Mar 10, 2025, 14:00 PM -
The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary
Mar 10, 2025, 14:00 PM -
Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?
Mar 10, 2025, 14:00 PM
